Enhanced biosynthesis of poly(3‐hydroxybutyrate) in engineered strains of Pseudomonas putida via increased malonyl‐CoA availability

Giusi Favoino,Nicolas Krink,Tobias Schwanemann,Nick Wierckx,Pablo I. Nikel
DOI: https://doi.org/10.1111/1751-7915.70044
2024-11-08
Microbial Biotechnology
Abstract:Malonyl‐coenzyme A (CoA) is a key precursor for the biosynthesis of high‐value compounds by microbial cell factories, including polyketides, carboxylic acids, biofuels, and polyhydroxyalkanoates (PHAs). Here, we engineered Pseudomonas putida, a versatile bacterial platform, for enhanced malonyl‐CoA availability, validating the engineered strains for enhanced PHA accumulation from sugars. Malonyl‐coenzyme A (CoA) is a key precursor for the biosynthesis of multiple value‐added compounds by microbial cell factories, including polyketides, carboxylic acids, biofuels, and polyhydroxyalkanoates. Owing to its role as a metabolic hub, malonyl‐CoA availability is limited by competition in several essential metabolic pathways. To address this limitation, we modified a genome‐reduced Pseudomonas putida strain to increase acetyl‐CoA carboxylation while limiting malonyl‐CoA utilization. Genes involved in sugar catabolism and its regulation, the tricarboxylic acid (TCA) cycle, and fatty acid biosynthesis were knocked‐out in specific combinations towards increasing the malonyl‐CoA pool. An enzyme‐coupled biosensor, based on the rppA gene, was employed to monitor malonyl‐CoA levels in vivo. RppA is a type III polyketide synthase that converts malonyl‐CoA into flaviolin, a red‐colored polyketide. We isolated strains displaying enhanced malonyl‐CoA availability via a colorimetric screening method based on the RppA‐dependent red pigmentation; direct flaviolin quantification identified four engineered strains had a significant increase in malonyl‐CoA levels. We further modified these strains by adding a non‐canonical pathway that uses malonyl‐CoA as precursor for poly(3‐hydroxybutyrate) biosynthesis. These manipulations led to increased polymer accumulation in the fully engineered strains, validating our general strategy to boost the output of malonyl‐CoA–dependent pathways in P. putida.
biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?